Application of cyclin-dependent kinase 9 inhibitor

The invention provides various applications of a compound as shown in a formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a prodrug thereof as a cyclin dependent kinase 9 (CDK9) inhibitor in treatment of hematologic tumors, especially leukemia, myeloma and lymphoma, including rela...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ZHAO CHUANWU, GAO NA, WANG JIA, HAO HONGRU, CHAI XIAOLING, FAN LIXUE, WEI BING
Format: Patent
Sprache:chi ; eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator ZHAO CHUANWU
GAO NA
WANG JIA
HAO HONGRU
CHAI XIAOLING
FAN LIXUE
WEI BING
description The invention provides various applications of a compound as shown in a formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a prodrug thereof as a cyclin dependent kinase 9 (CDK9) inhibitor in treatment of hematologic tumors, especially leukemia, myeloma and lymphoma, including related pharmaceutical uses, pharmaceutical compositions or treatment methods and the like. 本申请提供式(I)所示的化合物或其可药用盐、其立体异构体或前药作为周期蛋白依赖性激酶9(CDK9)抑制剂在治疗血液肿瘤,特别是白血病、骨髓瘤和淋巴瘤中的各种应用,包括相关的制药用途、药物组合物或治疗方法等。
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115381824A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115381824A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115381824A3</originalsourceid><addsrcrecordid>eNrjZDByLCjIyUxOLMnMz1PIT1NIrkzOyczTTUktSM1LSc0rUcjOzEssTlWwVMjMy8hMyizJL-JhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGpsYWhhZGJo7GxKgBALp9K-Y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Application of cyclin-dependent kinase 9 inhibitor</title><source>esp@cenet</source><creator>ZHAO CHUANWU ; GAO NA ; WANG JIA ; HAO HONGRU ; CHAI XIAOLING ; FAN LIXUE ; WEI BING</creator><creatorcontrib>ZHAO CHUANWU ; GAO NA ; WANG JIA ; HAO HONGRU ; CHAI XIAOLING ; FAN LIXUE ; WEI BING</creatorcontrib><description>The invention provides various applications of a compound as shown in a formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a prodrug thereof as a cyclin dependent kinase 9 (CDK9) inhibitor in treatment of hematologic tumors, especially leukemia, myeloma and lymphoma, including related pharmaceutical uses, pharmaceutical compositions or treatment methods and the like. 本申请提供式(I)所示的化合物或其可药用盐、其立体异构体或前药作为周期蛋白依赖性激酶9(CDK9)抑制剂在治疗血液肿瘤,特别是白血病、骨髓瘤和淋巴瘤中的各种应用,包括相关的制药用途、药物组合物或治疗方法等。</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221125&amp;DB=EPODOC&amp;CC=CN&amp;NR=115381824A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20221125&amp;DB=EPODOC&amp;CC=CN&amp;NR=115381824A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHAO CHUANWU</creatorcontrib><creatorcontrib>GAO NA</creatorcontrib><creatorcontrib>WANG JIA</creatorcontrib><creatorcontrib>HAO HONGRU</creatorcontrib><creatorcontrib>CHAI XIAOLING</creatorcontrib><creatorcontrib>FAN LIXUE</creatorcontrib><creatorcontrib>WEI BING</creatorcontrib><title>Application of cyclin-dependent kinase 9 inhibitor</title><description>The invention provides various applications of a compound as shown in a formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a prodrug thereof as a cyclin dependent kinase 9 (CDK9) inhibitor in treatment of hematologic tumors, especially leukemia, myeloma and lymphoma, including related pharmaceutical uses, pharmaceutical compositions or treatment methods and the like. 本申请提供式(I)所示的化合物或其可药用盐、其立体异构体或前药作为周期蛋白依赖性激酶9(CDK9)抑制剂在治疗血液肿瘤,特别是白血病、骨髓瘤和淋巴瘤中的各种应用,包括相关的制药用途、药物组合物或治疗方法等。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDByLCjIyUxOLMnMz1PIT1NIrkzOyczTTUktSM1LSc0rUcjOzEssTlWwVMjMy8hMyizJL-JhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHOfoaGpsYWhhZGJo7GxKgBALp9K-Y</recordid><startdate>20221125</startdate><enddate>20221125</enddate><creator>ZHAO CHUANWU</creator><creator>GAO NA</creator><creator>WANG JIA</creator><creator>HAO HONGRU</creator><creator>CHAI XIAOLING</creator><creator>FAN LIXUE</creator><creator>WEI BING</creator><scope>EVB</scope></search><sort><creationdate>20221125</creationdate><title>Application of cyclin-dependent kinase 9 inhibitor</title><author>ZHAO CHUANWU ; GAO NA ; WANG JIA ; HAO HONGRU ; CHAI XIAOLING ; FAN LIXUE ; WEI BING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115381824A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHAO CHUANWU</creatorcontrib><creatorcontrib>GAO NA</creatorcontrib><creatorcontrib>WANG JIA</creatorcontrib><creatorcontrib>HAO HONGRU</creatorcontrib><creatorcontrib>CHAI XIAOLING</creatorcontrib><creatorcontrib>FAN LIXUE</creatorcontrib><creatorcontrib>WEI BING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHAO CHUANWU</au><au>GAO NA</au><au>WANG JIA</au><au>HAO HONGRU</au><au>CHAI XIAOLING</au><au>FAN LIXUE</au><au>WEI BING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Application of cyclin-dependent kinase 9 inhibitor</title><date>2022-11-25</date><risdate>2022</risdate><abstract>The invention provides various applications of a compound as shown in a formula (I) or a pharmaceutically acceptable salt, a stereoisomer or a prodrug thereof as a cyclin dependent kinase 9 (CDK9) inhibitor in treatment of hematologic tumors, especially leukemia, myeloma and lymphoma, including related pharmaceutical uses, pharmaceutical compositions or treatment methods and the like. 本申请提供式(I)所示的化合物或其可药用盐、其立体异构体或前药作为周期蛋白依赖性激酶9(CDK9)抑制剂在治疗血液肿瘤,特别是白血病、骨髓瘤和淋巴瘤中的各种应用,包括相关的制药用途、药物组合物或治疗方法等。</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN115381824A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Application of cyclin-dependent kinase 9 inhibitor
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T12%3A00%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHAO%20CHUANWU&rft.date=2022-11-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115381824A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true